Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 101, Issue 1, Pages 187-199Publisher
WILEY-BLACKWELL
DOI: 10.1002/jps.22744
Keywords
adsorption; fluorescence spectroscopy; immunogenicity; microparticles; nanoparticles; protein aggregates; protein structure; recombinant human interferon beta; transgenics
Funding
- European Community [018926]
- Colorado University at Boulder, Utrecht Institute for Pharmaceutical Sciences
- Dutch Foundation for Pharmacological Sciences
Ask authors/readers for more resources
Aggregates play a major role in the immunogenicity of recombinant human interferon beta (rhIFN beta), a protein used to treat multiple sclerosis. A possible cause of aggregation is interaction between therapeutic protein and surfaces encountered during processing, storage, and administration. Moreover, proteins may adsorb to particles shed from these surfaces. In this work, we studied the immunogenicity of recombinant human interferon beta-1a (rhIFN beta-1a) interacting with glass microparticles, stainless steel microparticles, and polystyrene nanoparticles. At physiological pH, rhIFN beta-1a readily adsorbed to the particles, while the degree of adsorption was influenced by the ionic strength of the phosphate buffer. Front-face fluorescence showed that the tertiary structure of rhIFN beta-1a slightly changed upon adsorption to glass. The interaction with stainless steel microparticles resulted in increased levels of aggregates in the free protein fraction. Furthermore, protein adsorbed to stainless steel microparticles was more difficult to desorb than protein adsorbed to glass. Incubation with stainless steel considerably enhanced the immunogenicity of rhIFN beta-1a in transgenic mice immune tolerant for human interferon beta. The protein fraction adsorbed on stainless steel particles was responsible for this. In conclusion, rhIFN beta-1a adsorbs to common hydrophilic surface materials, possibly increasing the immunogenicity of the protein. (c) 2011 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:187199, 2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available